Saudi Arabia Genetic Testing Market, By Type (Carrier Testing, Diagnostic Testing, New-born Screening, Predictive & Pre-symptomatic Testing, Prenatal Testing, Others), By Disease (Sickle Cell Anemia, Thalassemia, Huntington's Disease, Cancer, Others), By Technology (Cytogenetic Testing, Biochemical Testing, Molecular Testing), By Service Providers (Clinical & Metabolic Specialists, Genetic Counsellors, Diagnostic Laboratories, Hospitals), By Region, Competition Forecast & Opportunities, 2027
Saudi Arabia genetic testing market is projected to register growth at a significant rate during the forecast period, 2023-2027. The market growth can be attributed to the rising incidences of genetic disorders in the country. Besides, rapidly mutating genes due to various environmental and other factors have led to the evolution of various genetic disorders, fueling the need for the diagnosis of genetic diseases.
The rising prevalence of illnesses like Down syndrome, sickle cell anemia, cancer, Thalassemia, etc., is also expected to aid market growth positively. Down syndrome is said to impact 1.8 out of every 1,000 live births in Saudi Arabia, according to the government's records of recent births in the nation. While the prevalence of sickle cell disease varies across the country, the Eastern region of the Kingdom of Saudi Arabia has between 91 and 99 instances for every 10,000 live births.
Moreover, the rising demand for genetic medications and personalized treatments that are created with higher disease specificity and cutting-edge technology are anticipated to fuel the growth of the Saudi Arabia genetic testing market. Clinical genetic testing was prohibited in response to the recent pandemic outbreak, which led to the rapid adoption of telemedicine-based consultations and counseling. Rising incidences of cancer and other chronic conditions have also led to genetic testing market growth in Saudi Arabia. Additionally, genetic testing of the virulent organism was done as part of the investigation of the SARS-CoV2 virus to comprehend its characteristics and roles in the creation of a vaccine and medication. Growth is also aided by improvements in the pharmaceutical industry and rising investment in its promotion.
The Saudi Arabia genetic testing market is segmented by type, disease, technology, service providers, competitional landscape, and regional distribution. Based on type, the market is further divided into carrier testing, diagnostic testing, newborn screening, predictive & pre-symptomatic testing, prenatal testing, and others. The diagnostic testing segment is expected to hold the largest share in the Saudi Arabia genetic testing market, owing to the increasing demand for early and effective diagnosis of chronic diseases. Based on the disease, the market is divided into sickle cell anemia, thalassemia, Huntington's disease, cancer, and others. The cancer sub-segment is anticipated to register the highest growth due to the rising instances of cancer among the population.
Major players operating in the Saudi Arabia genetic testing market are Anwa Medical Labs, NoorDX, Scientific Laboratories Alliance Company Ltd., ELAJ Group, Genetrack Biolabs, Johnson & Johnson, OncoDNA-International Medical Center, Baylor Genetics-King Faisal Specialist Hospital – Saudi Diagnostic Limited, among others.
Years considered for this report:
Historical Years: 2017-2020
Base Year: 2021
Estimated Year: 2022E
Forecast Period: 2023F–2027F
Objective of the Study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook